2,466
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Why do some participants in colorectal cancer screening choose not to undergo colonoscopy following a positive test result? A qualitative study

&
Pages 262-271 | Received 04 Sep 2017, Accepted 04 Jun 2018, Published online: 21 Sep 2018

References

  • Hakama M, Hristova L. Effect of screening in the Nordic cancer control up to the year 2017. Acta Oncol. 1997;36:119–128.
  • Vaccarella S, Franceschi S, Engholm G, et al. 50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence. Br J Cancer. 2014;111:965–969.
  • Engholm G, Ferlay J, Christensen N, et al. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries. Version 8.0 (20.12.2017). Association of the Nordic Cancer Registries. Danish Cancer Society [cited 15 Jan 2018]. Available from http://www.ancr.nu
  • Hewitson P, Glasziou P, Irwig L, et al. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev. 2007;1:CD001216.
  • Holme Ø, Bretthauer M, Fretheim A, et al. Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database Syst Rev. 2013;9:CD009259.
  • Riboe DG, Dogan TS, Brodersen J. Potential biases in colorectal cancer screening using faecal occult blood test. J Eval Clin Pract. 2013;19:311–316.
  • Sundhedstyrelsen, [The Danish Health Authorities]. Dansk, Tarmkraeftscreeningsdatabase Årsrapport. 2014 [The danish colorectal cancer screening database Annual Report 2014]. 2014 [cited Jan 2017]. Available at https://www.sundhed.dk/content/cms/45/61245_dts%C3%A5rsrapport-2014_8-1-16_final_inklbilag.pdf.
  • Leuraud K, Jezewski-Serra D, Viguier J, et al. Colorectal cancer screening by guaiac faecal occult blood test in France: Evaluation of the programme two years after launching. Cancer Epidemiol. 2013;37:959–967.
  • Weller D, Coleman D, Robertson R, et al. The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer. 2007;97:1601–1605.
  • Lin JS, Piper MA, Perdue LA, et al. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2016;315:2576–2594.
  • Kvale S, Brinkmann S. Interview: Introduktion til et håndvaerk. [Interview: Introduction to a craft]. Copenhagen: 2nd ed. Hans Rietzel; 2009.
  • Strauss A, Corbin J. Basics of qualitative research – techniques and procedures for developing grounded theory. 3rd ed. London: Sage; 2008.
  • Hestbech MS, Siersma V, Dirksen A, et al. Participation bias in a randomised trial of screening for lung cancer. Lung Cancer. 2011;73:325–331.
  • Wardle J, Williamson S, Sutton S, et al. Psychological impact of colorectal cancer screening. Health Psychol. 2003;22:54–59.
  • Lagerlund M, Hedin A, Sparen P, et al. Attitudes, beliefs, and knowledge as predictors of nonattendance in a Swedish population-based mammography screening program. Prev Med. 2000;31:417–428.
  • de Wijkerslooth TR, de Haan MC, Stoop EM, et al. Reasons for participation and nonparticipation in colorectal cancer screening: a randomized trial of colonoscopy and CT colonography. Am J Gastroenterol. 2012;107:1777–1783.
  • Marshall DA, Johnson FR, Phillips KA, et al. Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health. 2007;10:415–430.
  • Bo ZM, Ghevariya V, Ahluwalia M, et al. Barriers to colorectal cancer screening among African American population. J Clin Oncol Conf. 2010;28.
  • Oliffe J. Perceived barriers and benefits were factors in decision making about colorectal screening. Evidence Based Nursing. 2006;9:31.
  • McLachlan SA, Clements A, Austoker J. Patients' experiences and reported barriers to colonoscopy in the screening context-a systematic review of the literature. Patient Educ Couns. 2012;86:137–146.
  • McCaffery K, Borril J, Williamson S, et al. Declining the offer of flexible sigmoidoscopy screening for bowel cancer: A qualitative investigation of the decision-making process. Soc Sci Med. 2001;53:679–691.
  • Taggart N, Mbuyongha M, Fitzgerald G, et al. Understanding why the at-risk population do not take up colonoscopy following a positive screening test and attendance at nurse (SSP) assessment clinic within the bowel cancer screening programme (BCSP). Gut 2015;64:A401.
  • Plumb AA, Ghanouni A, Rainbow S, et al. Patient factors associated with non-attendance at colonoscopy after a positive screening faecal occult blood test. J Med Screen. 2017;24:12–19.
  • Ho W, Broughton DE, Donelan K, et al. Analysis of barriers to and patients' preferences for CT colonography for colorectal cancer screening in a nonadherent urban population. AJR Am J Roentgenol. 2010;195:393–397.
  • Enumah ZO, Atnafou R, Blum RW, "You Ain't Goin' in There!" promoters and barriers to colonoscopy screening Among African americans in East Baltimore Neighborhoods. Am J Gastroenterol. 2015;110:S624.
  • Wilkins T, Gillies RA, Harbuck S, et al. Racial disparities and barriers to colorectal cancer screening in rural areas. J Am Board Fam Med. 2012;25:308–317.
  • Mills KT, Bellows CF, Hoffman AE, et al. Diabetes mellitus and colorectal cancer prognosis: a meta-analysis. Dis Colon Rectum. 2013;56:1304–1319.
  • Diabetes foreningen [The diabetes association], Det Nationale Diabetesregister [The National Register of Diabetes]. [cited 15 Jan 2018]. Available at www.diabetes.dk.
  • Salter CI, Howe A, McDaid L, et al. Risk, significance and biomedicalisation of a new population: older women's experience of osteoporosis screening. Soc Sci Med. 2011;73:808–815.